Position in INVA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$243,996
-$122,980 QoQ
Shares Held
10,744
-41.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#197
of 306 holders
Holding Since
Mar 2023
3 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MIRABELLA FINANCIAL SERVICES LLP holds $3,358,382 across 9 Biotechnology names. INVA ranks #7 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
|
31,014 | $1,129,219 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
44,619 | $438,158 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
1,367 | $334,600 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,766 | $328,023 | |
| 5 | ABVX |
Abivax S.A.
|
2,337 | $311,428 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
3,009 | $261,632 | |
| 7 | INVA |
Innoviva, Inc.
This page
|
10,744 | $243,996 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
30,093 | $170,928 |
All Filings in INVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $243,996 | 10,744 | Shares | Sole | 2026-07-31 | |
| 2025-12-31 | $366,976 | 18,358 | Shares | Sole | 2026-02-17 | |
| 2023-03-31 | $244,530 | 21,736 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||